Ligand validation:5V7N

NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE

NAP is a Ligand Of Interest in 5V7N designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5V7N_NAP_B_401	95%	56%	0.071	0.973	0.87	0.84	2	2	0	0	100%	1
5V7N_NAP_A_401	94%	59%	0.073	0.97	0.85	0.72	2	-	1	0	100%	1
5V7N_NAP_C_401	90%	58%	0.079	0.963	0.78	0.83	1	-	0	0	100%	1
5V7N_NAP_D_401	89%	58%	0.083	0.961	0.81	0.8	2	1	0	0	100%	1
5V6Q_NAP_B_401	89%	60%	0.09	0.97	0.82	0.72	1	-	0	0	100%	1
2X9G_NAP_B_1269	100%	46%	0.031	0.997	0.96	1.14	1	5	0	0	100%	1
2J8T_NAP_A_1316	100%	49%	0.033	0.996	0.97	1.01	3	2	1	0	100%	1
3LQL_NAP_A_500	100%	43%	0.035	0.996	1.13	1.07	3	4	1	0	100%	1
4CQM_NAP_F_301	100%	49%	0.032	0.993	0.8	1.17	1	4	2	0	100%	1
3LD5_NAP_A_500	100%	31%	0.033	0.993	1.34	1.4	7	6	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.